Correlation Between Telkom Indonesia and Cue Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telkom Indonesia Tbk and Cue Biopharma, you can compare the effects of market volatilities on Telkom Indonesia and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and Cue Biopharma.

Diversification Opportunities for Telkom Indonesia and Cue Biopharma

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Telkom and Cue is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and Cue Biopharma go up and down completely randomly.

Pair Corralation between Telkom Indonesia and Cue Biopharma

Considering the 90-day investment horizon Telkom Indonesia Tbk is expected to generate 0.24 times more return on investment than Cue Biopharma. However, Telkom Indonesia Tbk is 4.23 times less risky than Cue Biopharma. It trades about -0.17 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.18 per unit of risk. If you would invest  1,856  in Telkom Indonesia Tbk on August 25, 2024 and sell it today you would lose (148.00) from holding Telkom Indonesia Tbk or give up 7.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Telkom Indonesia Tbk  vs.  Cue Biopharma

 Performance 
       Timeline  
Telkom Indonesia Tbk 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Telkom Indonesia Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Cue Biopharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Telkom Indonesia and Cue Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telkom Indonesia and Cue Biopharma

The main advantage of trading using opposite Telkom Indonesia and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.
The idea behind Telkom Indonesia Tbk and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies